Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
332 participants
OBSERVATIONAL
2020-04-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelets to Lymphocytes Ratio and Monocytes to Lymphocytes Ratio as Predictors of Response to Treatment in Cirrhotic Patients With Spontaneous Bacterial Peritonitis.
NCT05850858
Prediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.
NCT07116369
Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients
NCT03172013
Serum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
NCT05401721
Predicting and Monitoring Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using the Mansoura Scoring System
NCT07024355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Ascetic patients without spontaneous bacterial peritonitis
Measurement of mean platelet volume (MPV) and blood neutrophil to lymphocyte ratio (NLR)
MPV and NLR are easily accessible and inexpensive tests
Group 2
Ascetic patients with spontaneous bacterial peritonitis
Measurement of mean platelet volume (MPV) and blood neutrophil to lymphocyte ratio (NLR)
MPV and NLR are easily accessible and inexpensive tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurement of mean platelet volume (MPV) and blood neutrophil to lymphocyte ratio (NLR)
MPV and NLR are easily accessible and inexpensive tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who had received antibiotics before hospital admission.
* Patients on anticoagulant medications, NSAIDs, or oral contraceptive drugs.
* Patients with heart failure, diabetes mellitus, hypertension, hyperlipidemia, peripheral vascular disease, hematological disorders, and neoplastic disorders and patients with clinically overt hypothyroidism or hyperthyroidism or with clinically and laboratory-evident autoimmune diseases.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Abudeif Abdelaal, MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag Faculty of Medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-21-02-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.